# Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma

> **NCT03792867** · NA · UNKNOWN · sponsor: **National Cancer Centre, Singapore** · enrollment: 5 (actual)

## Conditions studied

- Retroperitoneal Sarcoma

## Interventions

- **DRUG:** Doxorubicin

## Key facts

- **NCT ID:** NCT03792867
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-23
- **Primary completion:** 2022-02-28
- **Final completion:** 2024-03-31
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2023-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792867, "Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03792867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*